Merck & Co. Inc. (MRK)

$ 113.71
   
  • Change Today:
    $1.34
  • 52 Week High: $123.18
  • 52 Week Low: $73.47
  • Currency: US Dollars
  • Shares Issued: 2,474.63m
  • Volume: 3,926,810
  • Market Cap: $281,390m
  • RiskGrade: 92

Latest ShareCast News

Shares jump as Merck lifts full-year guidance

By Abigail Townsend

Date: Wednesday 13 May 2026

(Sharecast News) - Shares in Merck sparked on Wednesday, after the German pharmaceuticals and technology giant boosted guidance on the back of a "solid" first quarter.

Merck beats Q1 forecasts on strong Keytruda demand

By Benjamin Chiou

Date: Thursday 30 Apr 2026

(Sharecast News) - Merck & Co beat market forecasts with its first-quarter results on Thursday and raised its full-year guidance on the back of strong growth for Keytruda, its flagship humanised monoclonal antibody (PD-1 inhibitor) used to treat 18 types of cancer.

Merck to buy Terns Pharmaceuticals for $6.7bn

By Michele Maatouk

Date: Wednesday 25 Mar 2026

(Sharecast News) - Merck said on Wednesday that it has agreed to buy Terns Pharmaceuticals, a clinical-stage oncology company, for $6.7bn.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 113.71
Change Today $ 1.34
% Change 1.19 %
52 Week High $123.18
52 Week Low $73.47
Volume 3,926,810
Shares Issued 2,474.63m
Market Cap $281,390m
RiskGrade 92

What The Brokers Say

Strong Buy 8
Buy 10
Neutral 10
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-May-2026

Time Volume / Share Price
15:47 100 @ $113.71
15:47 300 @ $113.71
15:47 100 @ $113.71
15:47 100 @ $113.71
15:47 100 @ $113.71

Top of Page